Literature DB >> 10944365

Medical abortion in social context.

C Joffe1.   

Abstract

Early medical abortion regimens, especially those that include mifepristone, have the potential to reshape the landscape of abortion provision in the United States. Because medical abortion does not require surgical training, it may attract new providers of abortion services from a variety of specialties, including advanced practice clinicians. The diffusion of abortion services into myriad clinical and office-based settings may reduce the violence that has been associated with abortion provision. However, a number of factors may slow the spread of medical abortion, at least initially. These factors include the need for accurate means to date early pregnancies, the need to arrange backup surgical services for the small number of patients who require them, the obligation to conform to existing legal mandates governing surgical abortion, and possible difficulties negotiating appropriate malpractice coverage and reimbursement. Educational initiatives are needed to help clinicians to overcome these barriers and to actualize mifepristone's potential in women's health care.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Substances:

Year:  2000        PMID: 10944365     DOI: 10.1067/mob.2000.108232

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Medication abortion in Canada: a right-to-health perspective.

Authors:  Joanna N Erdman; Amy Grenon; Leigh Harrison-Wilson
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

Review 2.  Medical liability insurance as a barrier to the provision of abortion services in family medicine.

Authors:  Christine E Dehlendorf; Kevin Grumbach
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

3.  Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008-2011 and 2014-2017.

Authors:  Rachel K Jones
Journal:  Contracept X       Date:  2020-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.